<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27793332</article-id>
<article-id pub-id-type="pmc">5318285</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2016.08.019</article-id>
<article-id pub-id-type="manuscript">NIHMS811762</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Enhancing the Informativeness and Replicability of Imaging Genomics Studies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Carter</surname>
<given-names>Cameron S.</given-names>
</name>
<aff id="A1">University of California at Davis, 4701 X Street Sacramento, CA 95816, phone 916 7348883 fax 916 7347884, <email>cameron.carter@ucdmc.ucdavis.edu</email></aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bearden</surname>
<given-names>Carrie E.</given-names>
</name>
<aff id="A2">University of California at Los Angeles</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bullmore</surname>
<given-names>Edward T.</given-names>
</name>
<aff id="A3">Cambridge University</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geschwind</surname>
<given-names>Daniel H.</given-names>
</name>
<aff id="A4">University of California at Los Angeles</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glahn</surname>
<given-names>David C.</given-names>
</name>
<aff id="A5">Yale University</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gur</surname>
<given-names>Raquel E.</given-names>
</name>
<aff id="A6">University of Pennsylvania</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meyer-Lindenberg</surname>
<given-names>Andreas</given-names>
</name>
<aff id="A7">University of Heidelberg Central Institute of Mental Health</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weinberger</surname>
<given-names>Danile R.</given-names>
</name>
<aff id="A8">Lieber Institute for Brain Development</aff>
</contrib>
</contrib-group>
<pub-date pub-type="nihms-submitted">
<day>31</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2018</year>
</pub-date>
<volume>82</volume>
<issue>3</issue>
<fpage>157</fpage>
<lpage>164</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2016.08.019-->
<abstract>
<p id="P1">Imaging genomics is a new field of investigation that seeks to gain insights into the impact of human genetic variation on the structure, chemistry and function of neural systems in health and disease. As publications in this field have increased over the past decade, increasing concerns have been raised about false positive results entering the literature. Here we provide an overview of the field of imaging genomic and genetic approaches, and discuss factors related to research design and analysis that can enhance the informativeness and replicability of these studies. We conclude that imaging genetic studies can provide important insights into the role of human genetic variation on neural systems and circuits, both in the context of normal quantitative variation and in relation to neuropsychiatric disease. We also argue that demonstrating genetic association to imaging-derived traits is subject to the same constraints as any other genetic study, including stringent Type I error control. Adequately powered studies are necessary; however, there are currently limited data available to allow precise estimates of effect sizes for candidate gene studies. Independent replication is necessary before a result can be considered definitive, and for studies with small sample sizes is necessary before publication. Increased transparency of methods and enhanced data sharing will further enhance replicability.</p>
</abstract>
<kwd-group>
<kwd>Imaging Genomics</kwd>
<kwd>Statistical Power</kwd>
<kwd>Sample Size</kwd>
<kwd>Multiple Comparisons</kwd>
<kwd>Replication</kwd>
<kwd>Clinical Confounds</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>